Mercury Bio and Himed Partner to Develop Novel Osteogenic Material for Orthopedic Applications

Mercury Bio, a biotech company based in Santa Fe, NM, has teamed up with Himed, a producer of bioceramics and biocompatible surface treatments for medical and dental implants. Together, they are working on developing an innovative osteogenic material specifically designed for orthopedic applications. The goal of this collaboration is to create a one-of-a-kind material that can be utilized in bon..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

Shorla Oncology Announces Licensing Agreement and Strategic Partnership for Rights to Market Chemotherapy Drug, PIP-101, in the United States

Shorla Oncology Announces Licensing Agreement and Strategic Partnership for Rights to Market Chemotherapy Drug, PIP-101, in the United States &nbsp The developer is a United Kingdom-based drug development and manufacturing company, providing integrated R&D and manufacturing capabilities to accelerate entry of PIP-101 in the U.S. market. Shorla Oncology to receive the exclusive rights to commerci..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 7.
  • textsms

Auxilius Pharma Raises Seed Round of $1 Million and Commences its Clinical Program

Auxilius Pharma has raised $1 million in seed funding to develop its lead asset, AUX-001, a new medication for treating chronic-stable angina pectoris in the US. The company is developing the drug as there have been very few medications developed to address chest pain symptoms suffered by patients with underlying coronary artery disease. Auxilius plans to conduct a first-in-human exploratory pha..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 20.
  • textsms